A Network of Early-Phase Clinical Research Environments
AccelsiorsĀ® works with closely collaborating early-phase clinical research units across Europe. These environments are selected and maintained for their scientific capability, regulatory track record, investigator expertise, and operational reliability.
Each unit offers a distinct profile ā in terms of infrastructure, therapeutic focus, participant access, and integration with broader clinical and academic ecosystems. This allows AccelsiorsĀ® to match each programme to the setting that best supports its specific requirements.
A key feature of several of our collaborating environments is their integration within tertiary healthcare institutions. This hospital-embedded model provides advantages that are difficult to replicate in standalone Phase I units:
- Direct access to both healthy volunteer and patient populations
- Proximity to specialist clinical departments ā including pediatric, oncology, cardiology, neurology, and metabolic medicine ā enabling patient referral and investigator collaboration within the same institution
- Hospital-grade infrastructure for safety monitoring, including overnight stays, intensive PK/PD sampling, and medical emergency response
- Pediatric clinical departments and pediatric investigators within the same institution, supporting early-phase pediatric studies with the oversight, ethical governance, and clinical expertise that these programmes require
Regulatory and ethics pathways established within European frameworks, including experience with pediatric-specific regulatory submissions
One of our closely collaborating environments is embedded within a public tertiary hospital in Thessaloniki, Greece. This setting provides:
- Direct access to both healthy volunteer and patient populations
- Hospital-grade infrastructure for safety monitoring, including overnight stays and intensive PK/PD sampling
- Proximity to specialist clinical departments, including pediatric departments, for patient-based and pediatric early-phase studies
- A research team with deep experience in Phase I and early Phase II execution
- Regulatory and ethics pathways established within the Greek and European frameworks
This environment is particularly well-suited for FIH studies requiring close medical oversight, biomarker-intensive protocols, studies bridging healthy volunteer and patient populations, and, notably, pediatric early-phase studies where hospital-integrated pediatric expertise is essential.
It is one example of how AccelsiorsĀ®Ā connects sponsors with the right research environment, not as a referral, but as an integrated part of the clinical development program.
